Guidelines and the role of non-statin therapies for high risk ASCVD patients - PACE-CME

Guidelines and the role of nonstatin therapies for high risk ASCVD patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Identifying patients for PCSK9 therapy
Identifying patients for PCSK9 therapy
Lessons from Landmark trials with PCSK9i
Identifying patients for PCSK9 therapy
- Kees Hovingh, MD
Landmark trials with PCSK9 inhibitors
Landmark trials with PCSK9 inhibitors
Lessons from Landmark trials with PCSK9i
Landmark trials with PCSK9 inhibitors
- Ph. Gabriel Steg, MD
PCSK9 inhibitors: How do they work?
PCSK9 inhibitors: How do they work?
Lessons from Landmark trials with PCSK9i
PCSK9 inhibitors: How do they work?